Black Diamond Therapeutics (BDTX) Operating Leases: 2020

Historic Operating Leases for Black Diamond Therapeutics (BDTX) over the last 1 years, with Dec 2020 value amounting to $7.7 million.

  • Black Diamond Therapeutics' Operating Leases rose 241.69% to $29.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $29.7 million, marking a year-over-year increase of 241.69%. This contributed to the annual value of $7.7 million for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, Black Diamond Therapeutics' Operating Leases is $7.7 million.
  • Over the past 5 years, Black Diamond Therapeutics' Operating Leases peaked at $7.7 million during FY2020, and registered a low of $7.7 million during FY2020.
  • Over the past 1 years, Black Diamond Therapeutics' median Operating Leases value was $7.7 million (recorded in 2020), while the average stood at $7.7 million.